Design of a Non-Interventional Study to Assess Neurologists’ Perspectives and Pharmacological Treatment Decisions in Early Alzheimer's Disease

Abstract Introduction The current therapeutic landscape of Alzheimer's disease (AD) is evolving rapidly. Our treatment options include new anti-amyloid-β protein disease-modifying therapies (DMTs) that decrease cognitive decline in patients with early AD (prodromal and mild AD dementia). Despit...

Full description

Bibliographic Details
Main Authors: Gustavo Saposnik, Gonzalo Sánchez-Benavidez, Elena García-Arcelay, Emilio Franco-Macías, Catalina Bensi, Sebastián Carmelingo, Ricardo F. Allegri, David A. Pérez-Martínez, Jorge Maurino
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-03-01
Series:Neurology and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s40120-023-00466-9